Edi Levi

3.7k total citations
105 papers, 2.9k citations indexed

About

Edi Levi is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Edi Levi has authored 105 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 39 papers in Molecular Biology and 23 papers in Surgery. Recurrent topics in Edi Levi's work include Cancer Cells and Metastasis (10 papers), Lymphoma Diagnosis and Treatment (8 papers) and Cutaneous lymphoproliferative disorders research (8 papers). Edi Levi is often cited by papers focused on Cancer Cells and Metastasis (10 papers), Lymphoma Diagnosis and Treatment (8 papers) and Cutaneous lymphoproliferative disorders research (8 papers). Edi Levi collaborates with scholars based in United States, Türkiye and Saudi Arabia. Edi Levi's co-authors include Adhip P.N. Majumdar, Fazlul H. Sarkar, Marshall E. Kadin, Yingjie Yu, Volkan Adsay, Olca Baştürk, David S. Klimstra, Lulu Farhana, Pratima Nangia‐Makker and O. Dereure and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Gastroenterology.

In The Last Decade

Edi Levi

105 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edi Levi United States 28 1.2k 1.1k 557 538 440 105 2.9k
Jawed A. Siddiqui United States 31 1.5k 1.3× 673 0.6× 236 0.4× 353 0.7× 181 0.4× 79 2.8k
Ting Li China 27 767 0.7× 972 0.9× 272 0.5× 354 0.7× 696 1.6× 172 2.6k
Chrisoula D. Scopa Greece 32 853 0.7× 624 0.6× 725 1.3× 390 0.7× 235 0.5× 98 2.7k
H Hiai Japan 25 1.7k 1.5× 489 0.5× 419 0.8× 309 0.6× 233 0.5× 47 3.4k
Makoto Nagashima Japan 29 2.1k 1.8× 954 0.9× 395 0.7× 726 1.3× 359 0.8× 75 3.6k
Xiaoli Li China 34 1.8k 1.5× 422 0.4× 259 0.5× 866 1.6× 153 0.3× 172 3.3k
Jelena Mann United Kingdom 36 2.0k 1.8× 468 0.4× 546 1.0× 692 1.3× 317 0.7× 65 5.0k
Feng Xue China 28 808 0.7× 225 0.2× 225 0.4× 290 0.5× 132 0.3× 87 2.3k
Yukio Ishikawa Japan 42 1.1k 1.0× 629 0.6× 1.2k 2.2× 398 0.7× 169 0.4× 107 4.2k
Chuan Liu China 28 1.3k 1.1× 436 0.4× 201 0.4× 603 1.1× 125 0.3× 121 2.3k

Countries citing papers authored by Edi Levi

Since Specialization
Citations

This map shows the geographic impact of Edi Levi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edi Levi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edi Levi more than expected).

Fields of papers citing papers by Edi Levi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edi Levi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edi Levi. The network helps show where Edi Levi may publish in the future.

Co-authorship network of co-authors of Edi Levi

This figure shows the co-authorship network connecting the top 25 collaborators of Edi Levi. A scholar is included among the top collaborators of Edi Levi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edi Levi. Edi Levi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tobi, Martin, Seema Sethi, Harvinder Talwar, et al.. (2024). Predicting Regression of Barrett’s Esophagus—Can All the King’s Men Put It Together Again?. Biomolecules. 14(9). 1182–1182. 2 indexed citations
2.
3.
Tobi, Martin, Douglas Weinstein, Mijin Kim, et al.. (2023). Helicobacter pylori Status May Differentiate Two Distinct Pathways of Gastric Adenocarcinoma Carcinogenesis. Current Oncology. 30(9). 7950–7963. 3 indexed citations
4.
Deitelzweig, Steven, Amiee Kang, Cristina Russ, et al.. (2021). EFFECTIVENESS AND SAFETY OF APIXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION ENROLLED IN MEDICARE AND VETERAN AFFAIRS. Journal of the American College of Cardiology. 77(18). 1593–1593. 1 indexed citations
5.
Sekhar, Sreeja C., Vino T. Cheriyan, Magesh Muthu, et al.. (2020). Antagonizing binding of cell cycle and apoptosis regulatory protein 1 (CARP-1) to the NEMO/IKKγ protein enhances the anticancer effect of chemotherapy. Journal of Biological Chemistry. 295(11). 3532–3552. 4 indexed citations
6.
Rossi, Noreen F., et al.. (2019). AT1 receptors in the subfornical organ modulate arterial pressure and the baroreflex in two-kidney, one-clip hypertensive rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 316(2). R172–R185. 6 indexed citations
7.
Liu, Yang, et al.. (2013). Cancer Stem Cells Biomarkers in Gastric Carcinogenesis. Journal of Gastrointestinal Cancer. 44(4). 428–435. 13 indexed citations
8.
Tobi, Martin, Mijin Kim, Douglas Weinstein, et al.. (2012). Prospective Markers for Early Diagnosis and Prognosis of Sporadic Pancreatic Ductal Adenocarcinoma. Digestive Diseases and Sciences. 58(3). 744–750. 8 indexed citations
9.
Levi, Edi, et al.. (2011). Video Capsule Endoscopy Findings in a Patient With Iron Deficiency Anemia. Gastroenterology. 142(1). e12–e13. 3 indexed citations
10.
Levi, Edi, Liyue Zhang, Amro Aboukameel, et al.. (2010). Cell cycle and apoptosis regulatory protein (CARP)-1 is a novel, adriamycin-inducible, diffuse large B-cell lymphoma (DLBL) growth suppressor. Cancer Chemotherapy and Pharmacology. 67(6). 1401–1413. 4 indexed citations
11.
Losanoff, Julian E., et al.. (2009). Amyloid tumor of the stomach simulating an obstructing gastric carcinoma: case report and review of the literature. Endoscopy. 41(S 02). E45–E46. 4 indexed citations
12.
Zhang, Pengfei, Joseph Bonventre, Susan C. Abraham, et al.. (2006). Liver & Pancreas. Laboratory Investigation. 86. 266–284. 1 indexed citations
13.
14.
Reddy, Sudha, Arun K. Rishi, Hu Xu, et al.. (2006). Mechanisms of Curcumin- and EGF-Receptor Related Protein (ERRP)-Dependent Growth Inhibition of Colon Cancer Cells. Nutrition and Cancer. 55(2). 185–194. 48 indexed citations
15.
Singh, Lalit P., et al.. (2006). Hexosamine induction of oxidative stress, hypertrophy and laminin expression in renal mesangial cells: effect of the anti‐oxidant α‐lipoic acid. Cell Biochemistry and Function. 25(5). 537–550. 37 indexed citations
16.
Adsay, Volkan, Olca Baştürk, Nihal Kılınç, et al.. (2005). A Proposal for a New and More Practical Grading Scheme for Pancreatic Ductal Adenocarcinoma. The American Journal of Surgical Pathology. 29(6). 724–733. 67 indexed citations
17.
Dereure, O., Edi Levi, Marshall E. Kadin, & Eric C. Vonderheid. (2002). Infrequent Fas Mutations but No Bax or p53 Mutations in Early Mycosis Fungoides: A Possible Mechanism for the Accumulation of Malignant T Lymphocytes in the Skin. Journal of Investigative Dermatology. 118(6). 949–956. 63 indexed citations
18.
Kadin, Marshall E., Edi Levi, & Werner Kempf. (2001). Progression of Lymphomatoid Papulosis to Systemic Lymphoma Is Associated with Escape from Growth Inhibition by Transforming Growth Factor‐β and CD30 Ligand. Annals of the New York Academy of Sciences. 941(1). 59–68. 25 indexed citations
19.
Pfeifer, Walther M., Edi Levi, Tina Petrogiannis‐Haliotis, et al.. (1999). A Murine Xenograft Model for Human CD30+ Anaplastic Large Cell Lymphoma. American Journal Of Pathology. 155(4). 1353–1359. 43 indexed citations
20.
Butmarc, Janet, Helen P. Kourea, Edi Levi, & Marshall E. Kadin. (1998). Improved Detection of CD5 Epitope in Formalin-Fixed Paraffin-Embedded Sections of Benign and Neoplastic Lymphoid Tissues by Using Biotinylated Tyramine Enhancement After Antigen Retrieval. American Journal of Clinical Pathology. 109(6). 682–688. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jawed A. Siddiqui Breakdown of academic impact, for papers by Ting Li Breakdown of academic impact, for papers by Chrisoula D. Scopa Breakdown of academic impact, for papers by H Hiai Breakdown of academic impact, for papers by Makoto Nagashima Breakdown of academic impact, for papers by Xiaoli Li Breakdown of academic impact, for papers by Jelena Mann Breakdown of academic impact, for papers by Feng Xue Breakdown of academic impact, for papers by Yukio Ishikawa Breakdown of academic impact, for papers by Chuan Liu
Rankless by CCL
2026